Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Risperdal Consta on Health Care Utilization Costs in Chronically Ill Schizophrenic Patients

NCT00313391 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00313391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00313391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Risperdal Consta on Health Care Utilization Costs in Chronically Ill Schizophrenic Patients
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia